ArticleTrials2024

HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial.

Thomas Bais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.